Figure 2.
Kaplan–Meier estimates of A) OS for patients receiving VEGF-targeted therapy, B) OS for patients receiving mTOR-targeted therapy, and C) OS for patients receiving IFN-a therapy stratified by ASI users versus non-users.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.